Open and Enrolling Clinical Trials

A Phase 1b Study to Evaluate the Safety and Clinical Activity of AB122 in Biomarker-Selected Participants with Advanced Solid Tumors
Sponsor: Arcus Biosciences, Inc.
Principal Investigator: Leon Hwang, MD
Contact: Leslie Greenberg, Clinical Trial Manager, 301-816-6768

A Prospective, Block Stratified Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System (Hologic-16-05B)
Sponsor: Hologic, Inc.
Principal Investigator: Ainsley MacLean, MD
Contact: Leslie Greenberg, Clinical Trial Manager, 301-816-6768

A Randomized, Phase II/III Study of Pegylated Lipsomal Doxorubicin and CTEP-Supplied Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Ovarian Cancer (NRG-GY009)
Sponsor: NRG Oncology
Principal Investigator: Leon Hwang, MD
Contact: Leslie Greenberg, Clinical Trial Manager, 301-816-6768

A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Sponsor: Alliance for Clinical Trials in Oncology
Principal Investigator: Leon Hwang, MD
Contact: Leslie Greenberg, Clinical Trial Manager, 301-816-6768

An Observational Study Profiling Biospecimens from Cancer Patients to Screen for Molecular Alterations (STR-001-001)
Sponsor: Strata Oncology
Principal Investigator: Leon Hwang, MD
Contact: Leslie Greenberg, Clinical Trial Manager, 301-816-6768

Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or Without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer
Sponsor: NRG Oncology
Principal Investigator: Leon Hwang, MD
Contact: Leslie Greenberg, Clinical Trial Manager, 301-816-6768

NCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study
Sponsor: National Cancer Institute
Principal Investigator: Leon Hwang, MD
Contact: Leslie Greenberg, Clinical Trial Manager, 301-816-6768

Pending IRB Approval: Utilization of Target Ranges to Treat Persons with Parkinson’s Disease by Objective Measurement Using the Personal KinetiGraph® (PKG®) compared to Standard of Care Assessment (TARGET-PwP)
Sponsor: Global Kinetics Pty Ltd
Principal Investigator: Ejaz Shamim, MD
Contact: Leslie Greenberg, Clinical Trial Manager, 301-816-6768

A Phase III Open-Label Clinical Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (microbiota suspension) in Subjects with Recurrent Clostridium difficile Infection (Rebiotix Open-Label)
Sponsor: Rebiotix Inc.
Principal Investigator: David Yoho, MD
Contact: Leslie Greenberg, Clinical Trial Manager, 301-816-6768

An open-label, non-randomized, prospective observational cohort study to assess post-procedural outcomes in two cohorts of women who chose to undergo either hysteroscopic sterilization (Essure®) or laparoscopic tubal sterilization (POET-ESSURE)
Sponsor: Bayer HealthCare, LLC
Principal Investigator: Kevin Smith, MD
Contact: Leslie Greenberg, Clinical Trial Manager, 301-816-6768